Get the Stockscreener App
2.25
0.90%
0.02
Oramed Pharmaceuticals Inc stock is traded at $2.25, with a volume of 48,084.
It is up +0.90% in the last 24 hours and up +7.66% over the past month.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.23
Open:
$2.23
24h Volume:
48,084
Relative Volume:
0.68
Market Cap:
$92.46M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
20.45
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
+2.27%
1M Performance:
+7.66%
6M Performance:
-12.45%
1Y Performance:
-4.26%
1-Day Range:
$2.23
$2.28
1-Week Range:
$2.13
$2.28
52-Week Range:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals Inc
Sector
Industry
Phone
646-844-1164
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.255 | 91.44M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.63 | 101.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.05 | 59.25B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.05 | 60.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
761.42 | 45.95B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.40 | 37.61B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-20-21 | Initiated | Canaccord Genuity | Buy |
| Feb-09-21 | Initiated | National Securities | Buy |
| Dec-03-20 | Initiated | Alliance Global Partners | Buy |
| Mar-11-20 | Initiated | Aegis Capital | Buy |
| Sep-11-19 | Initiated | Ladenburg Thalmann | Buy |
| Dec-11-17 | Resumed | B. Riley FBR, Inc. | Buy |
| May-26-16 | Reiterated | FBR Capital | Outperform |
| Dec-01-15 | Reiterated | H.C. Wainwright | Buy |
| Nov-19-15 | Initiated | FBR Capital | Outperform |
| Apr-13-15 | Resumed | MLV & Co | Buy |
| Jan-30-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Initiated | MLV & Co | Buy |
| Dec-03-13 | Initiated | Aegis Capital | Buy |
View All
Oramed Pharmaceuticals Inc Stock (ORMP) Latest News
Applying chart zones and confluence areas to Oramed Pharmaceuticals Inc.July 2025 Chart Watch & Verified Momentum Watchlists - Newser
Oramed Pharmaceuticals Inc. stock daily chart insightsWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Oramed Pharmaceuticals Inc. stock retracement – recovery analysisWeekly Investment Summary & Free Long-Term Investment Growth Plans - Newser
Price action breakdown for Oramed Pharmaceuticals Inc.Oil Prices & High Yield Stock Recommendations - Newser
Is this a good reentry point in Oramed Pharmaceuticals Inc.Inflation Watch & Technical Pattern Alert System - Newser
Chart based analysis of Oramed Pharmaceuticals Inc. trends2025 Technical Overview & Low Volatility Stock Recommendations - Newser
Does Oramed Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser
Applying big data sentiment scoring on Oramed Pharmaceuticals Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - Newser
Is Oramed Pharmaceuticals Inc. a top pick in the sectorPortfolio Value Report & Verified Momentum Stock Watchlist - خودرو بانک
Can Oramed Pharmaceuticals Inc. lead its sector in growth2025 Dividend Review & Intraday High Probability Setup Alerts - خودرو بانک
Will Oramed Pharmaceuticals Inc. outperform during market ralliesQuarterly Risk Review & Real-Time Volume Analysis Alerts - خودرو بانک
Sentiment analysis tools applied to Oramed Pharmaceuticals Inc.Jobs Report & Weekly Consistent Profit Watchlists - Newser
Is Oramed Pharmaceuticals Inc. forming a double bottomMarket Volume Summary & Verified Momentum Watchlists - خودرو بانک
Using Bollinger Bands to evaluate Oramed Pharmaceuticals Inc.Weekly Trend Recap & High Return Trade Opportunity Guides - Newser
What to expect from Oramed Pharmaceuticals Inc. in the next 30 days2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser
Is Oramed Pharmaceuticals Inc. forming a reversal patternEarnings Growth Summary & Community Verified Watchlist Alerts - Newser
Will Oramed Pharmaceuticals Inc. Sustain Its Chart BreakoutStop Loss & Long-Term Growth Stock Strategies - Newser
How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.Quarterly Growth Report & AI Powered Market Entry Ideas - Newser
How cyclical is Oramed Pharmaceuticals Inc.’s revenue streamWeekly Loss Report & Stock Portfolio Risk Management - خودرو بانک
Statistical indicators supporting Oramed Pharmaceuticals Inc.’s strength2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser
What to do if you’re stuck in Oramed Pharmaceuticals Inc.Dip Buying & Intraday High Probability Setup Alerts - Newser
Market Outlook: How cyclical is Oramed Pharmaceuticals Inc.’s revenue streamJuly 2025 Trends & Weekly Top Performers Watchlists - خودرو بانک
What MACD and RSI say about Oramed Pharmaceuticals Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Is a relief rally coming for Oramed Pharmaceuticals Inc. holdersTake Profit & Daily Growth Stock Investment Tips - Newser
Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Price Action Summary & Breakout Confirmation Alerts - Newser
Will Oramed Pharmaceuticals Inc. rebound enough to break evenPortfolio Risk Report & Real-Time Stock Entry Alerts - Newser
Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Growth Summary & Free Community Supported Trade Ideas - Newser
Tick level data insight on Oramed Pharmaceuticals Inc. volatility - Newser
Is Oramed Pharmaceuticals Inc. still worth holding after the dipEarnings Risk Report & AI Enhanced Trading Alerts - Newser
Can Oramed Pharmaceuticals Inc. sustain earnings growthEarnings Overview Report & Weekly Top Gainers Alerts - خودرو بانک
How sensitive is Oramed Pharmaceuticals Inc. to inflationJuly 2025 EndofMonth & Verified Entry Point Signals - خودرو بانک
Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Is Oramed Pharmaceuticals Inc. currently under institutional pressureWeekly Profit Analysis & Daily Profit Maximizing Tips - خودرو بانک
Does Oramed Pharmaceuticals Inc. stock reflect fundamentals2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک
Should you hold or exit Oramed Pharmaceuticals Inc. nowPortfolio Profit Report & Smart Allocation Stock Tips - Newser
What to do if you’re stuck in Oramed Pharmaceuticals IncTake Profit & Expert Curated Trade Setup Alerts - Newser
Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.07%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):